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1. Introduction 
Rat heart and skeletal muscle branched-chain 
2-oxoacid dehydrogenase (BCDH) complex is rapidly 
inactivated by ATP [l-6]; inactivation by ATP may 
result from phosphorylation [ 2,5,7] of the o-subunit 
of BCDH [ 81. Inactivation and phosphorylation are 
inhibited by ketoleucine [1,2,5,6]. Reactivation of 
inactive BCDH complexes may be effected with par- 
tially purified preparations of pyruvate dehydrogen- 
ase phosphate phosphatase [6]. In rat heart and in 
freshly prepared rat heart or skeletal muscle mito- 
chondria 85-95% of BCDH complex is in the inactive 
form [2,6]. Active complex is formed in mitochon- 
dria incubated with ketoleucine or depleted of ATP 
by incubation without respiratory substrate or by 
incubation with uncouplers; in mitochondria incu- 
bated with respiratory substrates 90-95% of complex 
is in the inactive form [2,6]. Active complex is 
formed in rat hearts perfused with medium contain- 
ing ketoleucine or leucine [6]. 
Only active BCDH complex has been detected in 
freshly prepared rat liver or kidney mitochondria 
[4,6]. Inactivation of BCDH complex by ATP was 
not detected although inactivation of the pyruvate 
dehydrogenase complex by ATP was detected in the 
same experiment [6]. This led to the suggestion of 
tissue-specific differences in the interconversion of 
active and inactive BCDH complexes between muscles 
Abbreviations: BCDH, branched-chain 2oxoacid dehydro- 
genase; EGTA, ethanedioxybis(ethylamine)-tetraacetate; 
TLCK, Nap-tosyl-L-lysine chloromethyl ketone; DTT, 
dithiothreitol; ketoleucine, 4-methyl-2oxopentanoate; keto- 
isoleucine, D,L-3-methyl-2oxopentanoate; ketovaline, 
3-methyl-2oxobutyrate; TPP, thiamin pyrophosphate; SDS, 
sodium dodecyl sulphate; CCCP, carbonyl cyanide m-chloro- 
phenylhydrazone 
66 
(on the one hand) and liver and kidney [6]. This 
could reflect, for example, for different isoenzymes 
of BCDH or absence or inhibition of the inactivating 
enzyme (presumed to be a protein kinase) in liver and 
kidney. It is shown here that BCDH complex in 
extracts of rat liver mitochondria is inactivated by 
ATP after a lag period but at a slower rate than the 
heart muscle complex. Inactivation of kidney com- 
plex is also shown; it was also slower and less exten- 
sive than that of heart muscle. Inactivation of liver 
and kidney complexes was inhibited by branched- 
chain 2-oxoacids and evidence is given that inactiva- 
tion may be associated with phosphorylation of the 
o-chain of BCDH. Evidence for ATP-induced phos- 
phorylation and inactivation of BCDH complex in rat 
kidney mitochondria has appeared in [9]. 
2. Experimental 
Sources of biochemicals and chemicals are given in 
[ 1,6]. [T-~“P] ATP was from the Radiochemical 
Centre, Amersham. Rat heart, liver and kidney mito- 
chondria were prepared as in [6]. Mitochondria were 
incubated (2.5 mg protein in 1 ml), separated and 
frozen as in [6]. The period of incubation was 30 min; 
aeration of medium was renewed at 6-8 min intervals 
by 1 s of vortex mixing. Additions to incubation 
medium are given in section 3. Extracts for assay of 
BCDH complex were prepared by ultrasonic disinte- 
gration of the frozen pellet into 250 111 extraction 
buffer (30 mM potassium phosphate/2 mM EDTA/ 
5 mM DTT/l mM TLCK/2% (v/v) ox-serum (pH 7.5 
BCDH complex was assayed in 100 ~1 extract. For 
1. 
ATPinactivation extracts were prepared as in [l] from 
frozen pellets of freshly prepared liver or kidney mito- 
chondria; or heart mitochondria incubated for 15 mm 
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without respiratory substrate [l]. The extraction 
buffer (see above) contained 10 mM EGTA in place 
of 2 mM EDTA and oligomycin B, 25 E.cg/ml. Extracts 
(5.3 mg mitochondrial protein/ml) were warmed to 
30°C (5 min) and reaction initiated with 0.05 vol. 
ATP+-branched chain 2-oxoacids (in controls buffer 
replaced ATP). BCDH complex was assayed on 140 /.d 
incubate. Incorporation of 32P from [T-~‘P] ATP 
(1500 dpm/pmol) into BCDH used the same buffer 
(100 ~1) with addition of 1 mM dichloroacetate to 
inhibit pyruvate dehydrogenase phosphorylation: 
dichloroacetate does not inhibit BCDH phosphoryla- 
tion or inactivation in mitochondrial extracts [2,5]. 
Reaction was terminated with trichloroacetic acid to 
10% (v/v), precipitated protein washed X6 with 1 ml 
10% trichloroacetic acid, dissolved in 250 111 50 mM 
Tris-HCl (PH 6.8) containing 1% (w/v) SDS, 150 mM 
2-mercaptoethanol, 10% (v/v) glycerol, 125 pg/ml 
bromophenol blue and neutralised (6 M NaOH). 
Samples (15 ~1) were subjected to SDS-polyacryl- 
amide gel electrophoresis in 8 X 7 X 0.2 cm slabs 
(10% polyacrylamide) at 70-75 V. Gel were pre- 
pared, and the running buffer (Tris-glycine) was as in 
[lo]. Autoradiographs of gels dried in vacua were 
prepared on Kodak Blue Brand BB5 X ray film. 
BCDH complex was asseyed spectrophotometrically 
by the initial rate of NAD’ reduction followed at 
30°C at 340 nm. The assay buffer (final vol. 1.4 ml) 
was 30 mM potassium phosphate/2 mM MgSOJ2 mM 
KCN/OA mM TPP/O.4 mM CoA/l mM NAD’10.2 mM 
ketoleucine/lO units lipoamide dehydrogenase/O.l% 
(v/v) Triton X-100 (PH 7.5). Extracts containing 
ketoisoleucine or ketovaline were assayed with the car- 
responding 2oxoacid in place of ketoleucine. Pro- 
gress curves were linear for at least 3 min (Gilford 
recording spectrophotometer; full scale extinction 
0.1). There was no detectable NADH oxidase activity 
in extracts under the conditions of assay. The blank 
rate (measured in the absence of branched-chain 
2-oxoacid) was negligible except for mitochondria 
incubated with glutamate (blank rate - 40% or with 
2-oxoglutarate t Lmalate (blank rate - 20%). These 
blank rates (which were subtracted) presumably 
reflect activities of glutamate, 2-oxoglutarate and 
malate dehydrogenases which are expressed when 
mitochondrial extracts contain their substrates. One 
unit of BCDH complex formed 1 /.m-rol NADH/min 
at 30°C. 
3. Results and discussion 
3 .l . Inactivation of BCDH complex by ATP in 
extracts of rat liver and kidney mitochondria 
In these experiments as in [I], Mg2+ for ATP inac- 
tivation was derived from mitochondria; the com- 
puted concentration was -160 PM. Further Mg*+ was 
not added because Mg*’ activates conversion of inac- 
tive BCDH complex into active complex [6]. The 
ATPase activity of mitochondrial extracts was limited 
by oligomycin B and restricting mitochondrial pro- 
tein concentration. Measured ATPase activities by the 
method in [ 1 l] (liver first) as % of 0.5 mM ATP 
were, 12,23 in 5 min, 26,36 in 10 min, 47,53 in 
20 min and 63,69 in 30 min (means of duplicate). 
As shown in fig.1 BCDH complex in extracts of 
liver mitochondria was inactivated by 0.5 mM ATP; 
inactivation was inhibited completely by 1.4 mM 
b I I I 1 10 20 30 40 
minutes of incubation 
Fig.1. Inactivation of branched-chain 2oxoacid dehydrogen- 
ase complex in extracts of rat liver mitochondria by ATP. 
Extracts of rat liver mitochondria were incubated with or 
without 0.5 mM ATP and assayed for branched-chain 2-oxo- 
acid dehydrogenase complex at times shown. Activities with 
ATP are shown as % of activity in control (incubation with- 
out ATP): (0) 0.5 mM ATP added at zero time; (a) 0.5 mM 
ATP + 1 A mM ketoleucine added at zero time; (A) 0.5 mM 
ATP added after 15 mm preincubation. Each point is mean of 
8 obs. The initial activity of BCDH complex was 6.01 units/g 
mitochondrial protein. P < 0.01 for difference from 100% 
for all (A); and for all (0) at or after 10 min; P > 0.05 for all 
other points. 
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ketoleucine. Inactivation by ATP only occurred after 
a lag period and significant ATP inactivation was first 
detected after 10 min incubation. This lag period was 
abolished by preincubation of mitochondrial extract 
for 15 min at 30°C prior to addition of ATP (fig.1). 
Inactivation by ATP was slow; -70% of complex was 
inactivated in 30 min (no preincubation) or 20 min 
tireincubation). Inactivation by ATP was much 
slower than in heart mitochondrial extracts in which 
complete inactivation is achieved in 10 min (see [ I] 
or table 1). In the experiments shown in fig.1 activity 
of BCDH complex (with ATP) is expressed as a per- 
centage of the control (incubated under otherwise 
identical conditions without ATP). The initial activity 
of BCDH complex in liver mitochondrial extracts was 
6.02 f 0.06 (mean + SEM) in units/g mitochondrial 
protein for 33 obs. on 4 mitochondrial preparations). 
Activity of BCDH complex in extracts incubated 
without ATP was stable and may have increased 
slightly. Activities as % of zero time were 98 ? 1.4 
(3min),106~3(6min),115~3(10min)119~1 
(20 min) and 111 + 1.3 (30 min) (mean + SEM) for 
8 obs.). 
Ketoleucine inhibited inactivation of BCDH com- 
plex in extracts of rat liver mitochondria (table 1); 
50% inhibition was achieved at 22-43 PM. Inhibition 
by ketoisoleucine was comparable to that of keto- 
leucine; inhibition by ketovaline was much less 
marked (table 1). In heart mitochondrial extracts 
(included for comparison) 50% inhibition by keto- 
leucine was achieved between 87 and 175 I.IM keto- 
leucine. Relative activities of liver BCDH complex 
with the three 2-oxoacids (line 1, table 1) were com- 
parable to those in [ 121. 
BCDH complex was inactivated by ATP in extracts 
of rat kidney mitochondria; activities (% of control 
lacking ATP) were 62% (5 min), 45% (10 min), 3 1% 
(20 min) and 27% (30 min) (mean of duplicates). 
Inactivation by 0.5 mM ATP was inhibited by 
1 mM ketoleucine; activities after 30 min were 
(mean f SEM; 4 obs.; units/g mitochondrial protein) 
4.6 + 0.09 (no ATP), 0.7 + 0.09 (ATP). 4.1 f 0.04 
(ATP + ketoleucine) (P < 0.001 for effects of ATP or 
ketoleucine). 
3.2. Incorporation of 32Pfrom (ys2P]ATP 
SDS-polyacrylamide gel electrophoresis in Tris- 
glycine of heart mitochondrial extracts incubated 
with [Y-~~P]ATP separates two bands of 32P corre- 
sponding in mobility to the o-chain of pyruvate 
Table 1 
Effect of branched-chain 2*xoacids on inactivation of rat liver and rat heart branched-chain 2exoacid dehydrogenase 
complex by ATP 
Branched-chain 2-oxoacid dehydrogenase complex activity (mean r SEM in units/g 
mitochondrial protein) 
Ketoacid 
(PM) 
Heart 
Ketoleucine 
Ketoleucine 
Liver 
- 
Ketoisoleucine Ketovaline 
0 (zero ATP) 2.75 + 0.04b (8) 6.1 ? 0.14b (8) 3.2 f 0.23b (4) 7.2 + 0.12b (4) 
0 -0.20 i 0.12a (7) 2.1 + 0.03a 
2.91 ? 0.09b (4) 
(8) 
1400 
2.55 t 0.09b (3) 
5.9 f 0.47b (12) 
1.5 f 0.05a (4) 
6.5 f 0.9gb 
3.3 c 0.06b (4) 
1.9 + 0.03a (4) 
4.8 * 0.17a,b (4) 
700 _ _ 
350 2.00 I O.Ola>b (4) 5.9 ? 0.1 lb 
(4) 
1.69 ?: 0.03a,b (3) 
(4) 2.6 + 0.23b (4) 2.0 i- 0.03a (4) 
175 - _ _ 
87 0.80 + 0.03a,b (3) - _ 
43 0.88 f 0.06a~b (3) 5.3 + 0.11ayb (7) 
2.6 f 0.05a,b (7) 
2.1 * 0.12a (4) _ 
22 _ _ _ 
11 _ 2.0 + 0.06a,b (8) _ 
aP < 0.01 against zero ATP; bP < 0.01 against zero ketoacid; no obs. in parentheses 
Mitochondrial extracts (5 mg Protein/ml) were incubated at 30°C with 0.5 mM ATP (except line 1, zero ATP) and ketoacid at fiM 
shown for 10 min (heart) or 20 min (liver). Branched-chain 2-oxoacid dehydrogenase complex activity was then assayed spectro- 
photometrically (NAD + reduction by A.JZ,,,), employing the ketoacid shown at the head of each column. For further details of 
methods used see section 2 
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Fig.2. Autoradiograph of SDS-polyacrylamide gel electro- 
phoresis in Tris-glycine buffer of rat liver and rat kidney 
mitochondrial extracts incubated with 0.5 mM [y-“P]ATP 
(1500 dpm/pmol) * 2 mM ketoleucine for 30 min at 30°C. 
Proteins were precipitated and washed (X6 with 10% tri- 
chloroacetic acid, taken up in SDS and neutralised and sub- 
jected to electrophoresis in 10% polyacrylamide. Tracks are 
(left-right): (l-4) liver, 0.5 mM ATP + 2 mM ketoleucine; 
(5-8) liver,0.5 mM ATP; (9,lO) kidney,0.5 mM ATP + 2 mM 
ketoleucine; (11 ,12) kidney, 0.5 mM ATP. For further details 
see section 2. The origin is at the top. 
dehydrogenase (M, - 43 000) and the (Y chain of 
BCDH (M, T 48 000). Incorporation into the lower 
M, band is inhibited by pyruvate and dichloroacetate; 
incorporation into the higher Mr band is inhibited by 
ketoleucine [ 51. Comparable data have been obtained 
with extracts of rat liver and kidney BCDH incubated 
with [y-32P]ATP, dichloroacetate + ketoleucine 
(fig.2). Autoradiographs showed 2 bands of radio- 
activity. The lower M, “P band was weak and poorly 
reproduced in fig.2 because extracts of freshly pre- 
pared rat liver or kidney mitochondria contain only 
-10% of active pyruvate dehydrogenase complex; 
and 32P incorporation into the pyruvate dehydrogen- 
ase complex was inhibited by 1 mM dichloroacetate. 
Incorporation of 32P into the higher IV, band was 
markedly inhibited by 1 mM ketoleucine. Ketoleu- 
tine is only a weak inhibitor of pyruvate dehydrogen- 
ase phosphorylation [ 111. Inactivation of rat liver and 
kidney BCDH complex by ATP may thus be corre- 
lated with phosphorylation of the a-subunit of 
BCDH. Incorporation of 32P from [y-32P]ATP into 
the a-subunit in BCDH in intact rat liver [8] and kid- 
ney [9] mitochondria has been suggested. 
3.3. BCDH activity in rat liver and kidney mito- 
chondria 
Because inactivation of BCDH complex by ATP in 
extracts of rat liver mitochondria and (to a lesser 
extent) rat kidney mitochondria was slow we have 
reinvestigated effects of respiratory substrates, 
uncouplers and ketoleucine on BCDH complex activ- 
ity in intact mitochondria with more prolonged incu- 
bation (30 min). No change in activity followed incu- 
bation with 5 mM glutamate f 1.4 mM ketoleucine 
(initial activity 5.6 f 0.06, 13 obs.; glutamate 
5.6 + 0.12,4 obs.; glutamate + ketoleucine 5.6 f 0.19, 
4 obs.; mean f SEM in units/g mitochondrial protein). 
A small decrease to 4.8 + 0.08 was observed with 
5 mM 2-oxoglutarate +0.5 mM Lmalate (mean f SEM; 
13 obs.; P < 0.001 against initial activity). This 
decrease was not reversed by 1.4 mM ketoleucine 
(4.6 f 0.12,9 obs.). In rat kidney mitochondria incu- 
bation for 30 min with 5 mM oxoglutarate + 0.5 mM 
Lmalate decreased BCDH complex activity from 
4.2 + 0.07 to 2.9 f 0.17 (mean f SEM for 4 obs. in 
units/g mitochondrial protein). This decrease in activ- 
ity waspreventedby 10/~MCCcP(4.1 *O.l7;4obs.) 
or 1.4 mM ketoleucine (4.3 f 0.15; 4 obs.). 
3.4. General discussion 
Evidence has been obtained in this study that rat 
liver and kidney BCDH complexes in extracts of mito- 
chondria are inactivated by phosphorylation with 
ATP. Inactivation of the liver complex was much 
slower than that of rat heart complex and only 
occurred after a lag period. This lag period was 
removed by preincubation of extracts. The data sug- 
gest either an inhibitor of the (presumed) kinase, or 
need for activation of the kinase, or need for inactiva- 
tion of the (presumed) phosphatase. The rate of inac- 
tivation of the kidney complex was intermediate 
between that of heart and liver complexes and no lag 
period was detected. The study has confirmed (cf. 
[6]) that freshly prepared rat liver and kidney mito- 
chondria contain little, if any, inactive BCDH com- 
plex: =G20% of BCDH complex in liver and <30% 
in kidney mitochondria was inactivated during 
30 min incubation with respiratory substrates. The 
results of this study lend further support to the sug- 
gestion [6] of tissue specific differences in the inter- 
conversion of inactive and active BCDH complexes. 
It would appear that the inactivating system is pres- 
ent in liver and kidney mitochondria but that its 
activity may not be expressed. The reason for this has 
yet to be elucidated. An encouraging feature of these 
findings is that liver BCDH complex may be used for 
exploring details of the interconversion of active and 
inactive BCDH complexes. Bat liver is a more conve- 
nient source of BCDH complex than rat muscles or 
kidney. 
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